Login / Signup

Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation.

Jianming YangYewu ChenHaobin SunXijian ZhangJianfeng WangZhixing LiangBinsheng FuTong ZhangShuhong YiYinan DengYang Yang
Published in: Infectious agents and cancer (2023)
Tenofovir decrease risk of HBV-Related Hepatocellular Carcinoma recurrence after liver transplantation compared to Entecavir.
Keyphrases
  • hepatitis b virus
  • free survival
  • antiretroviral therapy
  • drug induced